KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 83 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $14,629,156,000 | -17.0% | 291,708 | -42.6% | 0.01% | -22.2% |
Q4 2014 | $17,631,936,000 | +62238.9% | 508,418 | -41.1% | 0.01% | -40.0% |
Q3 2014 | $28,284,000 | -16.5% | 863,355 | -2.2% | 0.02% | -16.7% |
Q2 2014 | $33,875,000 | -99.9% | 882,853 | +9.2% | 0.02% | 0.0% |
Q1 2014 | $32,139,876,000 | +2.3% | 808,347 | -3.9% | 0.02% | 0.0% |
Q4 2013 | $31,426,178,000 | +1.0% | 841,397 | +23.3% | 0.02% | -5.3% |
Q3 2013 | $31,105,967,000 | +140.6% | 682,313 | +42.8% | 0.02% | +111.1% |
Q2 2013 | $12,926,573,000 | – | 477,877 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,810,518 | $71,986,000 | 2.98% |
Redmile Group, LLC | 443,326 | $17,627,000 | 2.10% |
AlpInvest Partners B.V. | 22,224 | $884,000 | 2.04% |
SENZAR ASSET MANAGEMENT, LLC | 89,500 | $3,558,000 | 1.88% |
Aureus Asset Management, LLC | 136,305 | $5,419,000 | 1.39% |
PFM Health Sciences, LP | 1,003,492 | $39,899,000 | 0.72% |
REGENTATLANTIC CAPITAL LLC | 176,454 | $7,016,000 | 0.68% |
Ghost Tree Capital, LLC | 25,000 | $994,000 | 0.59% |
HAMILTON LANE ADVISORS LLC | 30,264 | $1,203,000 | 0.48% |
Pentwater Capital Management LP | 390,000 | $15,506,000 | 0.41% |